Cargando…
Bioreactor-grown exo- and endo-β-glucan from Malaysian Ganoderma lucidum: An in vitro and in vivo study for potential antidiabetic treatment
This study aims to identify the roles of exo-β-glucan (EPS-BG) and endo-β-glucan (ENS-BG) extracted from Ganoderma lucidum (GL) in inhibiting the alpha-glucosidase enzyme, a target mechanism for postprandial hyperglycaemia regulation. Upscale production of GL was carried out using a 10 L bioreactor....
Autores principales: | Abdullah, Nur Raihan, Mohd Nasir, Mohd Hamzah, Azizan, Nur Hafizah, Wan-Mohtar, Wan Abd Al Qadr Imad, Sharif, Faez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452895/ https://www.ncbi.nlm.nih.gov/pubmed/36091430 http://dx.doi.org/10.3389/fbioe.2022.960320 |
Ejemplares similares
-
Pellet diameter of Ganoderma lucidum in a repeated-batch fermentation for the trio total production of biomass-exopolysaccharide-endopolysaccharide and its anti-oral cancer beta-glucan response
por: Abdullah, Nur Raihan, et al.
Publicado: (2020) -
Performance of wild-Serbian Ganoderma lucidum mycelium in treating synthetic sewage loading using batch bioreactor
por: Mohd Hanafiah, Zarimah, et al.
Publicado: (2019) -
The morphology of Ganoderma lucidum mycelium in a repeated-batch fermentation for exopolysaccharide production
por: Wan-Mohtar, Wan Abd Al Qadr Imad, et al.
Publicado: (2016) -
In vivo toxicity of bioreactor-grown biomass and exopolysaccharides from Malaysian tiger milk mushroom mycelium for potential future health applications
por: Usuldin, Siti Rokhiyah Ahmad, et al.
Publicado: (2021) -
Optimisation of biomass, exopolysaccharide and intracellular polysaccharide production from the mycelium of an identified Ganoderma lucidum strain QRS 5120 using response surface methodology
por: Supramani, Sugenendran, et al.
Publicado: (2019)